[Effect, in obese subjects, of the inhibition of beta-adrenergic receptors on the changes of glycemia, serum free fatty acids and glycerol, produced by glucagon].
D000273:Adipose Tissue / Q000294:innervation; D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D005934:Glucagon / Q000494:pharmacology*; D005990:Glycerol / Q000097:blood*; D006801:Humans; D006943:Hyperglycemia; D009765:Obesity; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D011941:Receptors, Adrenergic / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D011941:Receptors, Adrenergic; D013565:Sympatholytics; D005934:Glucagon; D011433:Propranolol; D005990:Glycerol
L'effet, chez les obèses, de l'inhibition des récepteurs bêta-adrénergiques sur les variations de la glycémie, des acides gras libres et du glycérol plasmatiques, produites par le glucagon.